Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Newsletter subscription
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Languages
ENGLISH
English (US)
ASIAN
Монгол
日本語
Tiếng Việt
Bahasa Indonesia
中文 (简体, 中国大陆)
EUROPEAN
Русский
Español (España)
Français (France)
MIDDLE_EAST_AFRICA
العربية
Home
/
About the Reporter
/
Park Pyeongtak
Park Pyeongtak
Reporter
Biowatch Team
With a background in Business Administration (MBA), I focus on the pharmaceutical and biotech industries. My goal is to select key information and present it in an easily understandable manner.
mail
ppt@kormedi.com
Latest Articles
Eli Lilly to Acquire GC Biopharma’s Curevo Vaccine in Blockbuster $1.5 Billion Deal
5/30/2026
Mexico Greenlights Daewoong’s Envlo, Fueling Latin American Expansion
5/29/2026
Daewoong Pharmaceutical Acquires U.S. Cellular Reprogramming Tech to Fast-Track Anti-Aging Therapeutics
5/26/2026
Oscotec Ramps Up R&D: What Lies Beyond the Success of Lazertinib?
5/22/2026
Rejuran Cosmetics Sales Surge 51%: PharmaResearch Finds New Growth Engine
5/17/2026
Celltrion to Acquire French Healthcare Specialist Gifrer, Eyeing European Pharmacy Market
5/14/2026
Daewoong Pharmaceutical Moves to Develop Once-Monthly GLP-1 Obesity Injection
5/12/2026
Rznomics and Inha University Confirm Potential for In-Vivo CAR-T Delivery Technology
4/7/2026
Previous
9
10
11
12
13
Next